Valisure

About:

Valisure is a digital pharmacy to chemically validate medications for quality and consistency.

Website: http://www.valisure.com

Twitter/X: valisure

Top Investors: City Light Capital, AlleyCorp, Realist Ventures, Daniel Borenstein

Description:

Valisure is launching the first digital pharmacy to chemically validate medications for quality and consistency. In response to rising concerns about counterfeit medications, insurance-mandated generics and overseas manufacturing in India and China, Valisure has developed novel, laser-based analytical technology that enables them to deliver medications to consumers that include a certificate of analysis specifying batch-validated dosage, inactive ingredients and other important properties. Medications are dispensed from Valisure only after the batch passes rigorous chemical analysis at the Valisure Lab. Valisure’s staff of Harvard and Yale-trained scientists strive to bring consumers the utmost quality. Valisure has ISO 17025 accreditation and is DEA and FDA registered.

Total Funding Amount:

$11.5M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

New Haven, Connecticut, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)valisure.com

Founders:

David Light

Number of Employees:

11-50

Last Funding Date:

2024-02-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai